207 related articles for article (PubMed ID: 37380085)
41. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
42. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q
Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114
[TBL] [Abstract][Full Text] [Related]
43. Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis.
Yin Q; Feng W; Shen X; Ju S
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30266744
[TBL] [Abstract][Full Text] [Related]
44. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
[TBL] [Abstract][Full Text] [Related]
45. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
46. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
47. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
49. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract][Full Text] [Related]
50. Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs.
Braga EA; Fridman MV; Burdennyy AM; Filippova EA; Loginov VI; Pronina IV; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362406
[TBL] [Abstract][Full Text] [Related]
51. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B
J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy.
Chen Y; Fu LL; Wen X; Liu B; Huang J; Wang JH; Wei YQ
Apoptosis; 2014 Aug; 19(8):1177-89. PubMed ID: 24850099
[TBL] [Abstract][Full Text] [Related]
53. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
54. The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.
Gao Y; Feng B; Han S; Zhang K; Chen J; Li C; Wang R; Chen L
Cell Physiol Biochem; 2016; 38(2):427-48. PubMed ID: 26828359
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.
Sha H; Gan Y; Xu F; Zhu Y; Zou R; Peng W; Wu Z; Ma R; Wu J; Feng J
J Cell Mol Med; 2022 Feb; 26(4):977-989. PubMed ID: 35014178
[TBL] [Abstract][Full Text] [Related]
56. MicroRNAs and prostate cancer.
Pang Y; Young CY; Yuan H
Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin α2 (KPNA2) and inactivate p53 signaling.
Tang G; Zhao H; Xie Z; Wei S; Chen G
Bioengineered; 2022 Mar; 13(3):7829-7846. PubMed ID: 35291921
[TBL] [Abstract][Full Text] [Related]
58. Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications.
Tapeh BEG; Mosayyebi B; Mansoori B; Gravand ZA; Sarvnaz H; Mohammadi A
Anticancer Agents Med Chem; 2021; 21(17):2304-2314. PubMed ID: 33596811
[TBL] [Abstract][Full Text] [Related]
59. miR-497 expression, function and clinical application in cancer.
Yang G; Xiong G; Cao Z; Zheng S; You L; Zhang T; Zhao Y
Oncotarget; 2016 Aug; 7(34):55900-55911. PubMed ID: 27344185
[TBL] [Abstract][Full Text] [Related]
60. The miR-17-92 cluster: Yin and Yang in human cancers.
Zhao W; Gupta A; Krawczyk J; Gupta S
Cancer Treat Res Commun; 2022; 33():100647. PubMed ID: 36327576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
